Analyst consensus rating
Opus Genetics Analyst Rating: Strong Buy
Direct answer
Opus Genetics's consensus rating is Strong Buy.
17 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $13.47.
Forecast evidence checked October 17, 2026.
Get free Opus Genetics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $3.84
- Average price target
- $13.47
- High price target
- $20.00
- Low price target
- $8.00
- Low target gap
- +108.3%
- Target upside
- +250.8%
- High target gap
- +420.8%
- Target range width
- 312.5%
- Consensus rating
- Strong Buy
- Analysts
- 17
- Evidence date
- October 17, 2026
- Valid through
- October 24, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Opus Genetics?
Opus Genetics has a verified Strong Buy consensus. The same dataset has an average price target of $13.47.
How far are Opus Genetics's low and high targets from the recorded price?
The low target implies +108.3%, while the high target implies +420.8%.
How many analysts are included in Opus Genetics's consensus?
The verified consensus includes 17 analysts.
How is Opus Genetics's target upside or downside calculated?
The average target of $13.47 is divided by the recorded price of $3.84, then one is subtracted to produce +250.8%. This does not guarantee a future return.
When was Opus Genetics's analyst forecast verified?
The data was verified on 2026-10-17. The dataset is valid through 2026-10-24.